JPRN-UMIN000012275已完成未知
Hangeshashinto for the prevention of oral mucositis in patients receiving with allogeneic hematopoietic stem cell transplantation - Hangeshashinto for the prevention of oral mucositis in patients receiving with allogeneic hematopoietic stem cell transplantation
orth Japan Hematology Study Group0 个研究点目标入组 72 人开始时间: 2013年11月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients seropositive for HIV or HBs. 2) Severe psychiatric illness or any disorder that compromises ability to give truly informed consent for participation in this study. 3) Pregnant or breastfeeding women. 4) Patient has another progressive malignant disease. 5) Uncontrolled infections. 6) Acute Myocardial Infarction and heart failure within the last 12 months. 7) Liver cirrhosis. 8) BMI>=35. 9) Arrhythmias: CTCAE v4.0 Grade>=3. 10) Contraindication of Hangeshashinto. 11) Oral mucositis: CTCAE v3.0 Grade>=3. 12) Patients who, in the judgment of the investigator, would be inappropriate for entry into this study.
研究者
相似试验
尚未招募
2 期
Ice popsicles for prevention of oral ulcer following anti-cancer therapy in children suffering from blood cancer.CTRI/2024/04/066130il
招募中
4 期
Prevention of oral mucositis in pediatric patients with acute lymphoblastic leukemia undergoing chemotherapy: a randomized controlled, cross-over trial using 0.12% chlorhexidine gluconate and 1% povidone iodine mouthwashoral mucositisCancer - Children's - Leukaemia & LymphomaOral and Gastrointestinal - Inflammatory bowel diseaseleukemiaACTRN12614000158662Amanda Christina C. Dujua, MD20
已完成
不适用
Study on prevention of severe oral mucositis for head and neck cancer patients with radiotherapyhead and neck cancerJPRN-UMIN000028813agasaki University Hospital10
已完成
3 期
Evaluation of Oral Care in preventing Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated with Everolimus: Randomized Controlled Phase III TrialMetastatic or recurrent breast cancerJPRN-UMIN000016109Oral Care-BC executive committee200
已完成
2 期
Prevention of the chemotherapy-induced oral mucositis by the rebamipide in breast cancer patients (Phase II)Oral mucositisJPRN-UMIN000005712Cinderella Study Group160